Hot Watch List: Cliffs Natural Resources Inc. (NYSE:CLF), Newmont Mining Corporation (NYSE:NEM), Alkermes plc (NASDAQ:ALKS), STR Holdings, Inc. (NYSE:STRI), Ariad Pharmaceuticals (NASDAQ:ARIA)

Cliffs Natural Resources (NYSE:CLF) last released its earnings data on Monday, October 27th. The company reported $0.21 EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.05) by $0.26. The company had revenue of $1.30 billion for the quarter, compared to the consensus estimate of $1.28 billion. During the same quarter in the prior year, the company posted $0.68 earnings per share. The company’s quarterly revenue was down 16.1% on a year-over-year basis. Analysts expect that Cliffs Natural Resources will post $0.11 EPS for the current fiscal year. Cliffs Natural Resources Inc. (NYSE:CLF) belongs to Basic Materials sector. Its weekly performance is -2.91%. On last trading day company shares ended up $10.69. Cliffs Natural Resources Inc. (NYSE:CLF) distance from 50-day simple moving average (SMA50) is -0.77%.

Newmont Mining Corporation (NYSE:NEM)’s CEO Gary J. Goldberg bought 5,000 shares of the company’s stock on the open market in a transaction that occurred on Tuesday, November 4th. The stock was purchased at an average price of $18.80 per share, for a total transaction of $94,000.00. Newmont Mining Corporation (NYSE:NEM) shares advanced 4.99% in last trading session and ended the day at $19.15. NEM Gross Margin is 35.80% and its return on assets is -2.30%. Newmont Mining Corporation (NYSE:NEM) quarterly performance is -28.52%.

Alkermes Plc (NASDAQ:ALKS) CEO Richard F. Pops sold 100,000 shares of the company’s stock on the open market in a transaction that occurred on Thursday, November 13th. The shares were sold at an average price of $52.87, for a total transaction of $5,287,000.00. Following the completion of the sale, the chief executive officer now directly owns 520,063 shares of the company’s stock, valued at approximately $27,495,731. On 14 November, Alkermes plc (NASDAQ:ALKS) shares decreased -3.29% and was closed at $51.47. ALKS EPS growth in last 5 year was -38.50%. Alkermes plc (NASDAQ:ALKS) year to date (YTD) performance is 26.59%.

STR Holdings, Inc. (NYSE:STRI) reported a loss of 11 cents per share in the third quarter of 2014, in line with the Zacks Consensus Estimate. In the prior-year quarter, the company had reported a net loss of 12 cents per share. On a GAAP basis, the company reported a loss of 15 cents per share compared with a loss of 14 cents per share in the year-ago quarter. The difference between GAAP and operating loss was due to a loss of 3 cents associated with discontinued operations. STR Holdings, Inc. (NYSE:STRI) ended the last trading day at $1.24. Company weekly volatility is calculated as 4.83% and price to cash ratio as 1.21. STR Holdings, Inc. (NYSE:STRI) showed a weekly performance of -0.80%.

Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) on Nov. 5 reported a third-quarter loss of $50.1 million. On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 27 cents. The results topped Wall Street expectations. The average estimate of analysts was for a loss of 30 cents per share. The company posted revenue of $14.7 million in the period, which did not meet Street forecasts. Analysts expected $16.7 million. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) belongs to Healthcare sector. Its weekly performance is 1.15%. On last trading day company shares ended up $6.15. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) distance from 50-day simple moving average (SMA50) is 7.26%.